• Currently, remdesivir is the only FDA-approved treatment for COVID-19, the data for which is conflicting.

  • All other recommendations below are based on in vitro data, non-robust trials, and expert opinion.

  • As there is no robust data to date, medications listed below should only be considered for patients with confirmed infection, or those at high risk for poor outcomes awaiting confirmation.

  • Clinical judgement should always be used to weigh the cost/benefit for individual cases.

This guideline will be continually updated as more evidence is published

More Information

See Adult COVID Treatment Guidelines on the intranet microsite for references

Last updated: 9.14.21 (inpatient & outpatient treatment)

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.